# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-299732
Filing Date
2018-10-16
Accepted
2018-10-16 07:20:45
Documents
39
Period of Report
2018-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d637736d8k.htm | 8-K | 17830
2 | EX-99.1 | d637736dex991.htm | EX-99.1 | 37616
3 | EX-99.2 | d637736dex992.htm | EX-99.2 | 27525
4 | GRAPHIC | g637736ex99_1s10g1.jpg | GRAPHIC | 248614
5 | GRAPHIC | g637736ex99_1s11g1.jpg | GRAPHIC | 321785
6 | GRAPHIC | g637736ex99_1s12g1.jpg | GRAPHIC | 331728
7 | GRAPHIC | g637736ex99_1s13g1.jpg | GRAPHIC | 289947
8 | GRAPHIC | g637736ex99_1s14g1.jpg | GRAPHIC | 263496
9 | GRAPHIC | g637736ex99_1s15g1.jpg | GRAPHIC | 497321
10 | GRAPHIC | g637736ex99_1s16g1.jpg | GRAPHIC | 43858
11 | GRAPHIC | g637736ex99_1s17g1.jpg | GRAPHIC | 330303
12 | GRAPHIC | g637736ex99_1s18g1.jpg | GRAPHIC | 301462
13 | GRAPHIC | g637736ex99_1s19g1.jpg | GRAPHIC | 402979
14 | GRAPHIC | g637736ex99_1s1g1.jpg | GRAPHIC | 529547
15 | GRAPHIC | g637736ex99_1s20g1.jpg | GRAPHIC | 351847
16 | GRAPHIC | g637736ex99_1s21g1.jpg | GRAPHIC | 342094
17 | GRAPHIC | g637736ex99_1s22g1.jpg | GRAPHIC | 388607
18 | GRAPHIC | g637736ex99_1s23g1.jpg | GRAPHIC | 342911
19 | GRAPHIC | g637736ex99_1s24g1.jpg | GRAPHIC | 343433
20 | GRAPHIC | g637736ex99_1s25g1.jpg | GRAPHIC | 57382
21 | GRAPHIC | g637736ex99_1s26g1.jpg | GRAPHIC | 336424
22 | GRAPHIC | g637736ex99_1s27g1.jpg | GRAPHIC | 325888
23 | GRAPHIC | g637736ex99_1s28g1.jpg | GRAPHIC | 323100
24 | GRAPHIC | g637736ex99_1s29g1.jpg | GRAPHIC | 76676
25 | GRAPHIC | g637736ex99_1s2g1.jpg | GRAPHIC | 608924
26 | GRAPHIC | g637736ex99_1s30g1.jpg | GRAPHIC | 382583
27 | GRAPHIC | g637736ex99_1s31g1.jpg | GRAPHIC | 251527
28 | GRAPHIC | g637736ex99_1s32g1.jpg | GRAPHIC | 304875
29 | GRAPHIC | g637736ex99_1s33g1.jpg | GRAPHIC | 379234
30 | GRAPHIC | g637736ex99_1s34g1.jpg | GRAPHIC | 210533
31 | GRAPHIC | g637736ex99_1s35g1.jpg | GRAPHIC | 367839
32 | GRAPHIC | g637736ex99_1s36g1.jpg | GRAPHIC | 527711
33 | GRAPHIC | g637736ex99_1s3g1.jpg | GRAPHIC | 86390
34 | GRAPHIC | g637736ex99_1s4g1.jpg | GRAPHIC | 247147
35 | GRAPHIC | g637736ex99_1s5g1.jpg | GRAPHIC | 376712
36 | GRAPHIC | g637736ex99_1s6g1.jpg | GRAPHIC | 52715
37 | GRAPHIC | g637736ex99_1s7g1.jpg | GRAPHIC | 276053
38 | GRAPHIC | g637736ex99_1s8g1.jpg | GRAPHIC | 236668
39 | GRAPHIC | g637736ex99_1s9g1.jpg | GRAPHIC | 52735
| Complete submission text file | 0001193125-18-299732.txt |  | 14977836

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 181123533
SIC: 2834 Pharmaceutical Preparations